Amgen bought Ch...
login
Shares
Bonds
π₯Pre-IPO
Dividends
Portfolio
More
ETF
Sectors
News
Calendar
Try for free
Login
×
Email
Password
Forgot your password?
Login
Resend my activation email
Need an account? Sign up.
Home
News
ChemoCentryx
Amgen bought ChemoCentryx
10/20/22 at 16:16
Share at
Vladimir Petenev
News editor
press@blackterminal.com
Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.
ChemoCentryx
Review
Source:
investors.amgen.com
Vladimir Petenev
News editor
Share at:
Share this news
×
To leave a comment, you must be logged in
Write your comment first
News feed
AbbVie reported for 3 months of 2023
4/27/23
ABBV
The Newmont Goldcorp announced a quarterly dividend
4/27/23
NEM
Altria Group reports 3 months of 2023
4/27/23
MO
Bristol-Myers Squibb reports 3 months of 2023
4/27/23
BMY
Comcast reported for 3 months of 2023
4/27/23
CMCSA
Newmont reported for 3 months of 2023
4/27/23
NEM
American Airlines reports 3 months of 2023
4/27/23
AAL
Eli Lilly has reported for 3 months of 2023
4/27/23
LLY
Honeywell International reports on 3 months of 2023
4/27/23
HON
Caterpillar reported 3 months of 2023
4/27/23
CAT
«
Previous
636
637
638
639
640
641
642
643
644
645
»
Next
BlackTerminal.com 2016 - 2025.
English (US)
English (US)
Π ΡΡΡΠΊΠΈΠΉ (Π Π€)